Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Blake E Max

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 2002
Assessing unit dose system discrepanciesBlake E Max, Gail Itokazu, Larry H Danziger, et al.
AIDS (London, England)|July 2, 2005
Response to 'limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'Sheila M Badri, Oluwatoyin M Adeyemi, Blake E Max, et al.
Infectious Diseases and Therapy|July 6, 2020
HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and BictegravirAlex E Rock, Patricia L DeMarais, Pamala T Vergara-Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
How does expert advice impact genotypic resistance testing in clinical practice?Sheila M Badri, Oluwatoyin M Adeyemi, Blake E Max, et al.
AIDS Patient Care and Stds|August 23, 2007
Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failureSheila M Badri, Oluwatoyin M Adeyemi, Blake E Max, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|May 15, 2002
Assessing unit dose system discrepanciesBlake E Max, Gail Itokazu, Larry H Danziger, et al.
AIDS (London, England)|July 2, 2005
Response to 'limited benefit of antiretroviral resistance testing in treatment-experienced patients: a meta-analysis'Sheila M Badri, Oluwatoyin M Adeyemi, Blake E Max, et al.
Infectious Diseases and Therapy|July 6, 2020
HIV-1 Virologic Rebound Due to Coadministration of Divalent Cations and BictegravirAlex E Rock, Patricia L DeMarais, Pamala T Vergara-Rodriguez, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2003
How does expert advice impact genotypic resistance testing in clinical practice?Sheila M Badri, Oluwatoyin M Adeyemi, Blake E Max, et al.
AIDS Patient Care and Stds|August 23, 2007
Utility of repeat genotypic resistance testing and clinical response in patients with three class resistance and virologic treatment failureSheila M Badri, Oluwatoyin M Adeyemi, Blake E Max, et al.
Pageof 1